Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study.
Thomas SilfverbergChristina ZjukovskajaPer LjungmanAdjmal NahimiErik AhlstrandArta DreimaneSigrun EinarsdottirJan FagiusEllen IacobaeusHans HägglundNiclas LangeStig LenhoffJan N LyckeJohan MellergårdFredrik PiehlAnders SvenningssonAndreas TolfHonar CherifKristina CarlsonJoachim BurmanPublished in: Journal of neurology, neurosurgery, and psychiatry (2023)
Treatment with aHSCT for RRMS is associated with freedom from disease activity in a majority of patients, with acceptable adverse events. This procedure should be considered a standard of care for patients with highly active RRMS.
Keyphrases
- multiple sclerosis
- disease activity
- stem cell transplantation
- systemic lupus erythematosus
- rheumatoid arthritis
- high dose
- rheumatoid arthritis patients
- ankylosing spondylitis
- healthcare
- white matter
- palliative care
- juvenile idiopathic arthritis
- quality improvement
- low dose
- minimally invasive
- combination therapy
- chronic pain
- pain management